Company profile: Iviva Medical
1.1 - Company Overview
Company description
- Provider of bioartificial kidney solutions for end-stage kidney disease, including fully implantable bioartificial kidneys; proprietary 3D-printed scaffold construction for human-scale solute-exchange grafts; Thin Film Interposition scaffolding; biologic blood purification with a cellular membrane-based device; and autologous renal grafts from patient-derived cells potentially eliminating the need for immunosuppression.
Products and services
- Bioartificial Kidneys: Fully implantable bioartificial kidneys engineered to replace kidney function for end-stage kidney disease patients
- Fully implantable
- Autologous Renal Grafts: Autologous renal grafts developed from patient-derived cells, potentially eliminating the need for immunosuppression in kidney function replacement therapies
- Autologous
- Human Scale Solute-Exchange Grafts: Human-scale solute-exchange grafts constructed using a matrix populated with multiple cell types to replace kidney function in renal disease
- Human-scale
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Iviva Medical
Tricida
HQ: United States
Website
- Description: Provider of pharmaceutical offerings within the healthcare industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tricida company profile →
Potrero Medical
HQ: United States
Website
- Description: Provider of predictive health technologies developing smart sensors and AI, including the Accuryn Monitoring System for real-time monitoring of urine output, intra-abdominal pressure, and core body temperature to detect acute kidney injury risk; AccuTab software for visualizing and annotating data; and Accuryn SmartFoley catheters designed to reduce CAUTIs by preventing urine backflow.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Potrero Medical company profile →
Judo Bio
HQ: United States
Website
- Description: Provider of precision therapeutics targeting specific cell populations to address genetic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Judo Bio company profile →
Angion Biomedica
HQ: United States
Website
- Description: Provider of clinical-stage organ restoration biopharmaceuticals focused on renal disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Angion Biomedica company profile →
Renibus Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics to prevent and treat kidney disease, with RBT-1 (single-dose IV before elective cardiac surgery to reduce post-operative complications; Phase 3), Veverimer (oral hydrochloric acid binder for orphan diseases), RBT-3 (iron nanoparticle to restore iron and improve blood product use in cardiac surgery and ER), RBT-9 (anti-inflammatory/antioxidant for COVID-19), and RBT-2 (oral antioxidant/antifibrotic to delay CKD).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renibus Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Iviva Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Iviva Medical
2.2 - Growth funds investing in similar companies to Iviva Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Iviva Medical
4.2 - Public trading comparable groups for Iviva Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →